CompletedPHASE2, PHASE3NCT01203345
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Studying Sepsis in premature infants
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- NICHD Neonatal Research Network
- Principal Investigator
- Avroy A. Fanaroff, MDCase Western Reserve University
- Intervention
- IVIG(drug)
- Enrollment
- 2416 target
- Eligibility
- All sexes
- Timeline
- 1988 – 1991
Study locations (8)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- George Washington University, Washington D.C., District of Columbia, United States
- University of Miami, Miami, Florida, United States
- Wayne State University, Detroit, Michigan, United States
- Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States
- University of Tennessee, Memphis, Tennessee, United States
- University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
- University of Vermont, Burlington, Vermont, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01203345 on ClinicalTrials.gov